High affinity quinoline-based kinase ligands
US7511063B2 · kind B2 · utility
0Cited by
0References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2006 |
| Grant date | Mar 31, 2009 |
| Priority date | — |
| Expiry date | Oct 7, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Quinoline-based inhibitors of cyclin dependent kinase 2, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions including them are useful for treating disease or disease symptoms. The invention also provides for methods of making CDK-2 inhibitor compounds, methods of inhibiting CDK-2, and methods for treating disease or disease symptoms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.